A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/275 (2006.01) A61K 31/13 (2006.01) A61K 31/135 (2006.01)
Patent
CA 2132416
The invention relates to the therapeutic treatment of hypertrophic scar tissue within a composition comprising a non-toxic transglutaminase inhibitor, such as putrescine, or a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutically acceptable carrier or diluent. A successful method for treating hypertrophic scar tissue with such compositions, is also disclosed.
L'invention se rapporte au traitement thérapeutique de tissus cicatriciels hypertrophiques dans une composition comprenant un inhibiteur de transglutaminase non toxique tel que la putrescine, ou un sel d'addition d'acide pharmaceutiquement acceptable, et un diluant ou un excipient pharmaceutiquement acceptable. Un procédé efficace, permettant de traiter des tissus cicatriciels hypertrophiques à l'aide de telles compositions, est également décrit.
Bowness John Michael
Dolynchuk Kenneth Nicholas
Bkp Gp
University Of Manitoba
LandOfFree
Use of transglutaminase inhibitor for the treatment of scar... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of transglutaminase inhibitor for the treatment of scar..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of transglutaminase inhibitor for the treatment of scar... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1890543